Health Economics and Outcome Research, Hartmann Group, Heidenheim, Germany.
Institute of Public Health, Medical Decision Making and HTA, UMIT, Hall in Tirol, Austria.
Int Wound J. 2023 Mar;20(3):792-798. doi: 10.1111/iwj.13924. Epub 2022 Sep 8.
Treatment of hard-to-heal wounds involves a holistic approach for choosing between available treatment options. However, evidence for informing these choices is sparse, introducing uncertainty into decisions about the optimum treatment pathways that reflect the vast heterogeneity in this patient population. This paper discusses the existing clinical and health economic literature in order to provide insight into sources of uncertainty in the evaluation of the holistic approach to management of the hard-to-heal wounds, and how this uncertainty can be appropriately reflected in research. We identified three key sources of uncertainty in the evaluation of chronic wound treatments, namely heterogeneity in aetiology and patient populations, heterogeneity in treatment pathways, and challenges around capturing all relevant outcomes. Reflecting these complexities requires sophisticated modelling of treatment sequencing and long-term outcomes. The paper discusses how the scope specification, scenario analyses, and sensitivity analyses can be used to fully characterise analytical uncertainty.
治疗难愈性伤口需要采取整体方法来选择可用的治疗方案。然而,用于指导这些选择的证据很少,这给反映患者人群巨大异质性的最佳治疗途径决策带来了不确定性。本文讨论了现有的临床和健康经济学文献,以深入了解评估整体方法管理难愈性伤口时不确定性的来源,以及如何在研究中适当地反映这种不确定性。我们确定了评估慢性伤口治疗方法时的三个关键不确定性来源,即病因和患者人群的异质性、治疗途径的异质性以及捕捉所有相关结局的挑战。反映这些复杂性需要对治疗顺序和长期结局进行复杂的建模。本文讨论了如何使用范围指定、情景分析和敏感性分析来充分描述分析不确定性。